Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Providence St. Joseph Hospital in California uses AI to boost breast cancer detection, identifying tumors earlier ...